Title : Androgen receptor as a potential druggable target in GBM
link : Androgen receptor as a potential druggable target in GBM
Androgen receptor as a potential druggable target in GBM
I took note of this abstract from the SNO 2017 abstracts:CSIG-24. ANDROGEN RECEPTOR IS A POTENTIAL THERAPEUTIC TARGET IN GLIOBLASTOMA (click on the title for the abstract)
The full study was just published in Oncotarget.
"The AR gene was amplified in 27% of glioblastoma specimens from men (n=22) and of 38.2% from women (n=21). AR-RNA was overexpressed (>2.5 fold) in 93% (n=30), and AR-protein was induced (>two fold) in 56% of the glioblastomas samples (n=16). Thirty percent of the glioblastomas (n=21) also expressed a constitutively active AR-splice-variant (AR-V7/AR3) lacking the Ligand-Binding-Domain."
"Enzalutamide given orally to nude mice bearing subcutaneous human glioma xenografts resulted in a 72% reduction in tumor volume (p=0.0027)."
Thus Article Androgen receptor as a potential druggable target in GBM
That's an article Androgen receptor as a potential druggable target in GBM This time, hopefully can give benefits to all of you. well, see you in posting other articles.
You are now reading the article Androgen receptor as a potential druggable target in GBM with the link address https://polennews.blogspot.com/2018/05/androgen-receptor-as-potential.html
0 Response to "Androgen receptor as a potential druggable target in GBM"
Post a Comment